Cargando…
Associations of Body Fat Distribution and Cardiometabolic Risk of Testicular Cancer Survivors After Cisplatin-Based Chemotherapy
BACKGROUND: It is unknown how body fat distribution modulates the cardiometabolic risk of testicular cancer survivors after cisplatin-based chemotherapy. METHODS: For 455 patients enrolled in the Platinum Study at Memorial Sloan Kettering Cancer Center, visceral (VAT) and subcutaneous (SAT) adipose...
Autores principales: | Wibmer, Andreas G, Dinh, Paul C, Travis, Lois B, Chen, Carol, Bromberg, Maria, Zheng, Junting, Capanu, Marinela, Sesso, Howard D, Feldman, Darren R, Vargas, Hebert Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263534/ https://www.ncbi.nlm.nih.gov/pubmed/35801305 http://dx.doi.org/10.1093/jncics/pkac030 |
Ejemplares similares
-
Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors
por: Kerns, Sarah L, et al.
Publicado: (2020) -
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
por: Fung, Chunkit, et al.
Publicado: (2018) -
Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms
por: Clasen, Suparna C., et al.
Publicado: (2021) -
Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors
por: Milano, Michael T, et al.
Publicado: (2020) -
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
por: Agrawal, Vaibhav, et al.
Publicado: (2019)